당뇨병 케어 기기 및 약제 시장 규모, 점유율, 성장 분석 : 유형별, 유통 채널별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Diabetes Care Devices and Drugs Market Size, Share, and Growth Analysis, By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital pharmacies, Retail Pharmacies), By End-use, By Region - Industry Forecast 2025-2032
상품코드:1677897
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
당뇨병 케어 기기 및 약제 시장 규모는 2023년에 301억 8,000만 달러로 평가되며, 2024년 325억 6,000만 달러에서 2032년에는 598억 3,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.9%로 성장할 전망입니다.
국제당뇨병연맹에 따르면 약 5억 3,700만 명의 성인이 앓고 있는 전 세계에서 급증하고 있는 당뇨병 환자들에게 인슐린 조절을 통한 혈당 조절은 매우 중요한 문제입니다. 당뇨병, 특히 2형 당뇨병의 유병률 증가는 특히 중저소득 국가에서 비만율 증가, 건강에 해로운 식습관, 좌식 생활습관 등에 기인합니다. 이러한 환자 수 증가는 혈당 관리를 간소화하는 지속형 혈당 측정기를 포함한 당뇨병 관리 기기에 대한 수요를 크게 촉진하고 있습니다. 특히 2형 당뇨병 진단 건수가 증가함에 따라 의료비 지출이 증가함에 따라 시장은 성장할 것으로 예상됩니다. 시장 세분화는 이 중요한 헬스케어 부문에서 더 큰 시장 점유율을 확보하기 위해 인슐린 전달 장비를 강화하기 위한 기술 혁신에 대한 투자를 늘리고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
당뇨병 케어 기기 및 약제 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
BGM 디바이스
자기 감시 디바이스
혈당 측정기
테스트 스트립
랜싯
연속 혈당 측정 기기
센서
송신기
수신기
인슐린 투여 기기
펌프
펜
주사기와 바늘
제트 인젝터
당뇨병 케어 기기 및 약제 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
병원 약국
소매 약국
당뇨병 클리닉/센터
온라인 약국
기타
당뇨병 케어 기기 및 약제 시장 규모 : 최종 용도별 & CAGR(2025-2032)
시장 개요
병원
진단 센터
홈케어
당뇨병 케어 기기 및 약제 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Novo Nordisk(Denmark)
Medtronic(Ireland)
Abbott Laboratories(United States)
Johnson & Johnson(United States)
Biocon(India)
Eli Lilly and Company(United States)
Roche(Switzerland)
Bayer(Germany)
Dexcom(United States)
Insulet Corporation(United States)
Tandem Diabetes Care(United States)
Ascensia Diabetes Care(Switzerland)
Terumo Corporation(Japan)
Becton, Dickinson and Company(United States)
AstraZeneca(United Kingdom)
Pfizer(United States)
Merck & Co.(United States)
GlaxoSmithKline(United Kingdom)
McKesson Corporation(United States)
결론과 제안
KSA
영문 목차
영문목차
Diabetes Care Devices and Drugs Market size was valued at USD 30.18 billion in 2023 and is poised to grow from USD 32.56 billion in 2024 to USD 59.83 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
The management of blood glucose levels through insulin regulation is critical for individuals with diabetes, a rapidly rising global health concern affecting approximately 537 million adults according to the International Diabetes Federation. The increasing prevalence of diabetes, particularly type 2, largely stems from rising obesity rates, unhealthy diets, and sedentary lifestyles, especially in low- and middle-income countries. This growing patient population significantly drives the demand for diabetes care devices, including continuous glucose monitors, which simplify glucose management. The market is poised for growth as healthcare costs escalate alongside the rising number of diagnoses, particularly for type 2 diabetes. Manufacturers are increasingly investing in technological innovations to enhance insulin delivery devices, aiming to capture larger market shares in this vital healthcare segment.
Top-down and bottom-up approaches were used to estimate and validate the size of the Diabetes Care Devices And Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Diabetes Care Devices And Drugs Market Segments Analysis
Global Diabetes Care Devices and Drugs Market is segmented by Type, Distribution Channel, End-use and region. Based on Type, the market is segmented into BGM Devices and Insulin Delivery Devices. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Diabetes Care Devices And Drugs Market
One of the primary catalysts for the expansion of the global diabetes care devices and drugs market is the continuous introduction of innovative products aimed at diabetes monitoring and treatment. A notable example is the research conducted by the Universidade de Lisboa in Portugal, which demonstrated in April 2020 that coating insulin-loaded nanoparticles with chitosan could significantly improve the oral delivery of insulin. Furthermore, the rising investments in research and development, along with collaborative efforts in the field, are expected to provide additional opportunities for market growth, reinforcing the overall advancement of diabetes management solutions.
Restraints in the Diabetes Care Devices And Drugs Market
The growth of the global diabetes care devices and drugs market may be hindered by several factors, including limited reimbursement options, stringent regulations, and increasing obesity rates in certain regions. Additionally, the lack of awareness surrounding diabetes diagnosis and treatment, particularly in emerging markets, poses a significant challenge to market expansion. These obstacles can lead to reduced accessibility and adoption of diabetes care solutions, further impeding the development of the market. Addressing these issues will be essential to enhance growth prospects and improve the overall effectiveness of diabetes management strategies worldwide.
Market Trends of the Diabetes Care Devices And Drugs Market
The Diabetes Care Devices and Drugs market has experienced a notable positive trend, catalyzed by the COVID-19 pandemic, which heightened awareness and concern over diabetes management among patients. With diabetics facing elevated risks from the virus, the demand for advanced monitoring devices surged as individuals sought to manage their condition more effectively from home. This shift resulted in a significant increase in the adoption of home-based diabetes care solutions, driven by a desire to minimize hospital visits. As a result, the market has seen innovations in drug formulations and device technology aimed at improving blood glucose monitoring and overall diabetes management, indicating a sustained growth trajectory in response to evolving patient needs.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Diabetes Care Devices and Drugs Market Size by Type & CAGR (2025-2032)
Market Overview
BGM Devices
Self-Monitoring Devices
Blood Glucose Meters
Testing Strips
Lancets
Continuous Glucose Monitoring Devices
Sensors
Transmitters
Receiver
Insulin Delivery Devices
Pumps
Pens
Syringes and Needles
Jet Injectors
Global Diabetes Care Devices and Drugs Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others
Global Diabetes Care Devices and Drugs Market Size by End-use & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostic Centers
Homecare
Global Diabetes Care Devices and Drugs Market Size & CAGR (2025-2032)
North America (Type, Distribution Channel, End-use)
US
Canada
Europe (Type, Distribution Channel, End-use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Distribution Channel, End-use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Distribution Channel, End-use)
Brazil
Rest of Latin America
Middle East & Africa (Type, Distribution Channel, End-use)
